About Vineet Life Sciences Limited
Data last updated:
Vineet Life Sciences Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 21 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24211TG2014PLC092453. Its GSTIN is 37AAFCV1330G1ZK (Andhra Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹9.93 Cr. It was formerly known as Vineet Life Sciences Private Limited. It is led by directors including Gaddam Venkata Ramana (Managing Director) and Satyanarayana Raju Bhupathiraju.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No.3 – 15 – 72/B4/26 Bahar – B Sahara States Mansoorabad Lb Nagar, Hyderabad, Telangana, India – 500070.
As per the financials filed for FY 2024, the company reported a revenue of ₹101.85 Cr, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹1.19 Cr (net margin 1.2%) and EBITDA of ₹6.04 Cr (EBITDA margin 5.9%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 261% over five years.
The company has about 38 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Vineet Life Sciences. As per MCA filings, the company has open charges of ₹26.7 Cr and satisfied charges of ₹17.85 Cr on record. Court records list 1 case involving the company. The company has 5 deals on record (3 funding rounds, 2 rights issues), with disclosed funding of ₹8.14 Cr; the latest was in June 2021. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Lucent Drugs Private Limited with revenue of ₹104.13 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vineetlife.in.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH.No.3 – 15 – 72/B4/26 Bahar – B Sahara States Mansoorabad Lb Nagar, Hyderabad, Telangana, India – 500070
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Vineet Life Sciences Limited
The main business activity of Vineet Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Vineet Life Sciences Limited FY 2024 filings available
Vineet Life Sciences Limited reported revenue of ₹101.85 Cr (up 48% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Vineet Life Sciences Limited
Revenue has grown at a compounded annual rate (CAGR) of 261% over five years, including 48% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Vineet Life Sciences Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.04 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.19 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vineet Life Sciences Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vineet Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Vineet Life Sciences Limited
Vineet Life Sciences Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lucent Drugs Private Limited | ₹104.13 Cr (FY 2025) | •••• | •••• | 101.0% | •••• | Sanathnagar, Telangana, India |
| Novo Excipients Private Limited | ₹103.54 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Mumbai, Maharashtra, India |
| Par Active Technologies Private Limited | ₹103.46 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Chennai, Tamil Nadu, India |
| Avik Pharmaceutical Limited | ₹103.38 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Mumbai, Maharashtra, India |
| Sriven Pharmachem India Private Limited | ₹102.76 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Hyderabad, Telangana, India |
| Vineet Life Sciences Limited this company | ₹101.85 Cr (FY 2024) | •••• | •••• | 48.0% | •••• | Hyderabad, Telangana, India |
| Sna Healthcare Private Limited | ₹101.57 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| Sarv Bio Labs Private Limited | ₹101.4 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Himachal Pradesh, India |
| Valens Molecules Private Limited | ₹100.32 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Hyderabad, Telangana, India |
| Ketul Chem Private Limited | ₹98.92 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Mumbai, Maharashtra, India |
| Warren Remedies Private Limited | ₹98.74 Cr (FY 2025) | •••• | •••• | 2320.0% | •••• | Aurangabad, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Vineet Life Sciences by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Vineet Life Sciences Limited
Vineet Life Sciences has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaddam Venkata Ramana Also directs: Vineet Laboratories Limited, Vineet Chem Trade Private Limited, Wohler Laboratories Private Limited and 1 more | Managing Director | 21 Jan 2014 | 12 Years 8 Months | Current |
| Satyanarayana Raju Bhupathiraju Also directs: Vineet Laboratories Limited | Director | 29 Nov 2018 | 7 Years 10 Months | Current |
| Kandula Murali Mohan | Director | 21 Jan 2014 | 12 Years 8 Months | Current |
| Varaprasada Rao Valluru Also directs: Satyadeva Organosys Private Limited | Director | 18 Apr 2015 | 11 Years 5 Months | Current |
Charges & Borrowings of Vineet Life Sciences Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Mar 2024 | Hdfc Bank Limited | ₹26.7 Cr | Open |
| 28 Oct 2019 | State Bank of India | ₹17.85 Cr | Satisfied |
Total charge records: 2 View all charges
Deals & Funding of Vineet Life Sciences Limited
Vineet Life Sciences Limited has 5 deals on record (3 funding rounds, 2 rights issues), with disclosed funding of ₹8.14 Cr; the latest was in June 2021.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2021 | Rights issue | ₹1.7 Cr | Investors: 4 individuals |
| Jun 2021 | Funding round | ₹9 Lakh | Investors: 3 individuals |
| May 2021 | Rights issue | ₹9.4 Lakh | Investors: an individual |
| Mar 2020 | Funding round | ₹5.88 Cr | Investors: 4 individuals |
| Mar 2018 | Funding round | ₹2.18 Cr | Investors: 4 individuals |
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Vineet Life Sciences Limited
Vineet Life Sciences Limited has 1 court case on record: 1 where it is another party. All case is disposed. Status as checked on 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Andhra Pradesh | Writ petition | Company is another party | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Vineet Life Sciences Limited
Vineet Life Sciences operates one associated brand: Vineet Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures intermediates for active pharmaceutical ingredients and fine chemicals. | vineetlife.in |
Employees and EPFO Compliance at Vineet Life Sciences Limited
Employment history and EPFO contributions of people linked to Vineet Life Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Vineet Life Sciences Limited
Vineet Life Sciences has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24211TG2014PLC092453, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24211TG2014PLC092453 | Current |
| U24211AP2014PTC092453 | Previous |
| U24211TG2014PTC092453 | Previous |
Recent Activity on Vineet Life Sciences Limited
Vineet Life Sciences Limited has 8 board changes on record since 2014: 4 appointments and 4 cessations. The latest: Poojaben Vasantbhai Gamit ceased to be Director on 21 Jun 2025.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Vineet Life Sciences Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vineet Life Sciences Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vineet Life Sciences Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vineet Life Sciences Limited
Vineet Life Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAFCV1330G1ZK | Andhra Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vineet Life Sciences Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vineet Life Sciences Limited
Vineet Life Sciences is an active public limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 21 January 2014 (12+ years old) and is registered under CIN U24211TG2014PLC092453.
Vineet Life Sciences reported revenue of ₹101.85 Cr for FY 2024 (up 48% YoY).
Vineet Life Sciences has 4 current directors:
- Gaddam Venkata Ramana - Managing Director
- Satyanarayana Raju Bhupathiraju - Director
- Kandula Murali Mohan - Director
- Varaprasada Rao Valluru - Director
Vineet Life Sciences reported a net profit of ₹1.19 Cr (net margin 1.2%) and EBITDA of ₹6.04 Cr (EBITDA margin 5.9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Vineet Life Sciences is 35% over three years and 261% over five years. In the latest year (FY 2024) revenue rose 48%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Vineet Life Sciences is 37AAFCV1330G1ZK, registered in Andhra Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Vineet Life Sciences is U24211TG2014PLC092453. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vineet Life Sciences has 1 court case on record.
Vineet Life Sciences was incorporated on 21 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
Vineet Life Sciences has 5 deals on record (3 funding rounds, 2 rights issues), with disclosed funding of ₹8.14 Cr; the latest was in June 2021.
The peers of Vineet Life Sciences by revenue are Lucent Drugs Private Limited, Novo Excipients Private Limited, Par Active Technologies Private Limited, Avik Pharmaceutical Limited, Sriven Pharmachem India Private Limited and 5 more, all in the Pharma industry (API Manufacturers).